
Sign up to save your podcasts
Or


December 18, 2025
CAP statement on prehospital transfusions
Peer-to-Peer: Michael Laposata, MD, PhD, FCAP
A small molecule inhibitor of RNA-binding protein IGF2BP3 shows anti-leukemic activity
Targeting ‘undruggable’ protein that fuels aggressive leukemia
CAP Transfusion, Apheresis, and Cellular Therapy Committee
Hosted on Ausha. See ausha.co/privacy-policy for more information.
By College of American Pathologists3.3
33 ratings
December 18, 2025
CAP statement on prehospital transfusions
Peer-to-Peer: Michael Laposata, MD, PhD, FCAP
A small molecule inhibitor of RNA-binding protein IGF2BP3 shows anti-leukemic activity
Targeting ‘undruggable’ protein that fuels aggressive leukemia
CAP Transfusion, Apheresis, and Cellular Therapy Committee
Hosted on Ausha. See ausha.co/privacy-policy for more information.

56,827 Listeners